Search hospitals > Ohio > Elyria
Mercy Cancer Center-Elyria
Claim this profileElyria, Ohio 44035
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
150 reported clinical trials
20 medical researchers
Summary
Mercy Cancer Center-Elyria is a medical facility located in Elyria, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Mercy Cancer Center-Elyria is involved with conducting 150 clinical trials across 321 conditions. There are 20 research doctors associated with this hospital, such as Shahzad Siddique, David Bajor, M.D., Richard T. Lee, and Debora S. Bruno.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Shahzad SiddiquePenrose-Saint Francis Healthcare4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
111 reported clinical trials
176 drugs studied
David Bajor, M.D.University Hospitals Cleveland Medical Center4 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
11 reported clinical trials
22 drugs studied
Richard T. LeeCity of Hope Medical Center4 years of reported clinical research
Studies Cancer
Studies Biliary Tract Cancer
10 reported clinical trials
21 drugs studied
Debora S. BrunoCase Western Reserve University3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
19 drugs studied
Clinical Trials running at Mercy Cancer Center-Elyria
Breast Cancer
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Carcinoma
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Lung Cancer
Gastric Cancer
Esophageal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Cancer Center-Elyria?
Mercy Cancer Center-Elyria is a medical facility located in Elyria, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Mercy Cancer Center-Elyria is involved with conducting 150 clinical trials across 321 conditions. There are 20 research doctors associated with this hospital, such as Shahzad Siddique, David Bajor, M.D., Richard T. Lee, and Debora S. Bruno.